rs632111
Positions:
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_000511.6(FUT2):c.*1733A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.442 in 166,880 control chromosomes in the GnomAD database, including 17,310 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.44 ( 15995 hom., cov: 31)
Exomes 𝑓: 0.42 ( 1315 hom. )
Consequence
FUT2
NM_000511.6 3_prime_UTR
NM_000511.6 3_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.268
Genes affected
FUT2 (HGNC:4013): (fucosyltransferase 2 (H blood group)) This gene is one of two encoding the galactoside 2-L-fucosyltransferase enzyme. The encoded protein is important for the final step in the soluble ABO blood group antigen synthesis pathway. It is also involved in cell-cell interaction, cell surface expression, and cell proliferation. Mutations in this gene are a cause of the H-Bombay blood group where red blood cells lack the H antigen. [provided by RefSeq, May 2022]
MAMSTR (HGNC:26689): (MEF2 activating motif and SAP domain containing transcriptional regulator) Predicted to enable transcription coregulator activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to act upstream of or within positive regulation of myotube differentiation and positive regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.497 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FUT2 | NM_000511.6 | c.*1733A>G | 3_prime_UTR_variant | 2/2 | ENST00000425340.3 | NP_000502.4 | ||
FUT2 | NM_001097638.3 | c.*1733A>G | 3_prime_UTR_variant | 2/2 | NP_001091107.1 | |||
MAMSTR | XM_047438640.1 | c.*1547T>C | 3_prime_UTR_variant | 7/7 | XP_047294596.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FUT2 | ENST00000425340.3 | c.*1733A>G | 3_prime_UTR_variant | 2/2 | 1 | NM_000511.6 | ENSP00000387498.2 |
Frequencies
GnomAD3 genomes AF: 0.445 AC: 67568AN: 151780Hom.: 16002 Cov.: 31
GnomAD3 genomes
AF:
AC:
67568
AN:
151780
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.416 AC: 6237AN: 14984Hom.: 1315 Cov.: 0 AF XY: 0.413 AC XY: 2942AN XY: 7116
GnomAD4 exome
AF:
AC:
6237
AN:
14984
Hom.:
Cov.:
0
AF XY:
AC XY:
2942
AN XY:
7116
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.445 AC: 67570AN: 151896Hom.: 15995 Cov.: 31 AF XY: 0.433 AC XY: 32140AN XY: 74210
GnomAD4 genome
AF:
AC:
67570
AN:
151896
Hom.:
Cov.:
31
AF XY:
AC XY:
32140
AN XY:
74210
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
474
AN:
3418
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at